DMRADamora Therapeutics, Inc.

$29.13

What is the market doing?

What the tape says about DMRA

Damora Therapeutics, Inc. is +764% over the past year while the S&P 500 is +20%: 744 points ahead of the market.

+764%

1-year return · S&P 500 +20%

vs 200-day average
+15%

vs 200-day average · a clear uptrend

RSI (14)
41

RSI (14) · neutral

Below its 52-week high
15%

Below its 52-week high

2024-08-15$2.22 – $34.14 · dashed line: 200-day average2026-09-08
Details
Last close2026-09-08
$29.13
1 monthS&P 500 −0.30%
−2.6%
1 yearS&P 500 +20%
+764%
5 yearsS&P 500 +85%
−73%
vs 50-day average$28.03
+3.9%
52-week high
$34.14
52-week low
$2.58
Annualised volatility
343%
Calendar-year price return
YearReturn
2026 (year to date)+27%
2025+395%
2024−74%
2023−37%
2022−62%
2021−76%
Average return by calendar month, 2020–2026
MonthYearsPositiveAverage
Jan63 of 6+14%
Feb62 of 6−4.2%
Mar62 of 6−11%
Apr60 of 6−11%
May62 of 6−1.5%
Jun63 of 6+3.8%
Jul63 of 6+7.7%
Aug62 of 6−11%
Sep64 of 6+1.6%
Oct52 of 5+5.0%
Nov63 of 6+17%
Dec63 of 6−1.0%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.